"Central California’s premier comprehensive cancer care center"

During the past decade, Community Cancer Institute conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 13 clinical trials were completed, i.e. on average, 37.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 9 clinical trials were completed. i.e. 56.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Community Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "NRG Oncology" with 2 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "University of California, San Francisco" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Community Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Community Cancer Institute" are "Breast Adenocarcinoma" (4 trials), "Invasive Breast Carcinoma" (3 trials), "Recurrent Breast Carcinoma" (3 trials), "Sarcomatoid Renal Cell Carcinoma" (3 trials) and "Stage IB Lung Non-Small Cell Carcinoma AJCC v7" (3 trials). Many other conditions were trialed in "Community Cancer Institute" in a lesser frequency.

Most popular intervention types in "Community Cancer Institute" are "Drug" (42 trials), "Other" (33 trials), "Biological" (23 trials), "Procedure" (18 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (17 trials), "Quality-of-Life Assessment" (15 trials), "Computed Tomography" (10 trials), "Nivolumab" (9 trials) and "Questionnaire Administration" (9 trials). Other intervention names were less common.

The vast majority of trials in "Community Cancer Institute" are 38 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Community Cancer Institute". undefined are not yet recruiting, 13 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Community Cancer Institute, 5 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Community Cancer Institute, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".